F. Lanas et al., EFFECTIVENESS OF DIGOXIN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE INSINUS RHYTHM, Revista Medica de Chile, 122(10), 1994, pp. 1147-1152
Due to differences in treatment effect in studies on the effectiveness
of digoxin in patients with congestive heart failure in sinus rhythm,
a cross-over placebo-controlled, randomized double blind clinical tri
al was performed. Thirty one patients, without previous treatment with
digoxin, in New York Heart Association (NYHA) functional class II to
IV, with a dilated left ventricle and/or ventricular systolic dysfunct
ion were included. Patients received digoxin, adjusted for blood level
s, or placebo, during an 8 week period, prior to crossing over to the
other treatment for another 8 weeks. The order of treatments was rando
mly allocated. Outcome measurement were performed at the end of each 8
week period. Digoxin, compared with placebo, improved NYHA class, 6.9
% vs 41.4% (p = 0.013) and increased the treadmill exercise time, 406
+/- 204 s vs 484 +/- 185 s (p = 0.003). During the digoxin treatment t
he left ventricular and systolic diameter was reduced from 52.9 +/- 8.
9 to 50.1 +/- 9.7 mm (p = 0.016) and the shortening fraction increased
from 21.4 +/- 8.3 to 24.8 +/- 8.1% (p = 0.009). No significant differ
ence was observed in the left ventricular end diastolic diameter (LVED
) of the left ventricle and in a estimation of quality of life. In con
clusion, digoxin treatment produced a significant improvement in funct
ional capacity, exercise time, and left ventricular performance.